Tiz01 (Tiz01)
Tizanidne Hydrochloride Capsule
Product Images NDC 76420-231
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 76420-231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Tiz02 (Tiz02)
Tiz03 (Tiz03)
Tiz04 (Tiz04)
The text describes the improvement in Ashworth Score for patients taking tizanidine at a mean dose of 26.8 mg. The Ashworth Score is a measure of spasticity in muscles, and Tizanidine is a medication used to treat spasticity. The score is measured at the end of titration, at the end of maintenance, and at the study endpoint, as observed in a study.*
Tiz05 (Tiz05)
The text is describing the packaging of Tizanidine HCI Capsules, a prescription drug packaged by Enovachem and distributed by Ascend Laboratories in varying quantities (30, 60, and 90). The capsules are described as "Shelopaque capsule/BMG:Taa" or "vdopaae opsle UG T i" and contain 6mg of the active ingredient. The lot and batch numbers are listed for each quantity. The package insert includes a cautionary statement regarding federal law, keeping the drug away from children, and storage instructions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
